04/12/2026
Texas Congressman Nathaniel Moran (TX-01) recently issued a stark warning in a commentary for The Hill titled "America’s medicine cabinet runs through Beijing," highlighting a dangerous shift in the global pharmaceutical landscape.
Moran argues that the United States has reached a perilous turning point regarding its medical supply chain. Currently, the U.S. is deeply beholden to China for essential drug components, even as Beijing aggressively moves to dominate clinical trials and drug production. According to Moran, this lopsided relationship is more than a trade imbalance; it is a direct threat to national security and the well-being of American patients. Any escalation in geopolitical friction could effectively sever the American public's access to vital medications.
While the U.S. has historically been the pioneer of medical breakthroughs, Moran emphasizes that this leadership is under siege. He calls on Congress to implement long-term reforms that incentivize domestic R&D and manufacturing to counter China’s rapid expansion in the sector.
"Congress must continue to focus on policies that spur pharmaceutical innovation at home beyond the immediate future because China has and will continue to outpace the U.S.," Moran writes. He maintains that the next wave of medical miracles must be "discovered, developed, and produced" on American soil to ensure the safety of the free world.
Read the full piece here: https://thehill.com/opinion/healthcare/5817380-us-china-drug-innovation/
The United States is increasingly reliant on China for pharmaceuticals, with the potential for the Chinese Communist Party to gain control of the global supply chain, posing a national security ris…
